Virax Biolabs Group Limited (VRAX)

NASDAQ: VRAX · Real-Time Price · USD

2.880

-0.100 (-3.36%)

At close: Aug 10, 2026, 4:00 PM EDT

2.910

+0.030 (1.04%)

After-hours: Aug 10, 2026, 7:57 PM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
Distribution of Diagnostics Test Kits and PPE Products	12.42K	6.33K	156.42K	8.56K		123.82K
Total	12.42K	6.33K	156.42K	8.56K		123.82K

Revenue by Geography

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
United Kingdom	12.42K	6.33K	156.42K	8.56K		123.82K
Total	12.42K	6.33K	156.42K	8.56K		123.82K